News
ProgenaMatrix - ProgenaCare Global
03/12/2024
A 100-patient interventional clinical study will evaluate the efficacy of ProgenaMatrix in the management of DFUs with the primary outcome of time to wound closure at 12 weeks in patients not responding to traditional moist therapy. Not yet recruiting; the estimated study completion is Sept 2026. clinicaltrials.gov
